The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The TimesShire Plc has pledged itself to an independent future by striking a $5.2 billion deal to purchase NPS Pharmaceuticals Inc, a specialist developer of medicines for rare diseases. (thetim.es/1snBuu5)
NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide. Shares of NPSP fell by 2.35% or $-1.01/share to $41.91. In the past year, the shares have traded as low as $22.11 and as high as $42.95. On average, 1585980 shares of NPSP exchange hands on a given day and today's volume is recorded at 1091052.
Source
